Works by Czerwiec, Frank S.

Results: 18

FP046 A PHASE 2 DOSE-RANGING STUDY COMPARING PHARMACOKINETICS (PK), PHARMACODYNAMICS (PD), AND TOLERABILITY OF MODIFIED RELEASE (MR) VS IMMEDIATE RELEASE (IR) TOLVAPTAN (TLV) IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) PATIENTS (PT).

Published in:

Nephrology Dialysis Transplantation, 2019, v. 34, p. N.PAG, doi. 10.1093/ndt/gfz106.FP046

By:

Perrone, Ronald;
Chapman, Arlene;
Oberdhan, Dorothee;
Czerwiec, Frank S;
Sergeyeva, Olga;
Ouyang, John;
Shoaf, Susan

Publication type:

Article

FP045 NOCTURNE: A PHASE 2, RANDOMIZED, PLACEBO-CONTROLLED TRIAL TO COMPARE TOLVAPTAN (TLV) MODIFIED-RELEASE (MR) AND IMMEDIATE-RELEASE (IR) FORMULATIONS IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) PATIENTS (PT).

Published in:

Nephrology Dialysis Transplantation, 2019, v. 34, p. N.PAG, doi. 10.1093/ndt/gfz106.FP045

By:

Perrone, Ronald;
Chapman, Arlene;
Oberdhan, Dorothee;
Czerwiec, Frank S;
Sergeyeva, Olga;
Ouyang, John;
Shoaf, Susan

Publication type:

Article

Can we further enrich autosomal dominant polycystic kidney disease clinical trials for rapidly progressive patients? Application of the PROPKD score in the TEMPO trial.

Published in:

Nephrology Dialysis Transplantation, 2018, v. 33, n. 4, p. 645, doi. 10.1093/ndt/gfx188

By:

Cornec-Le Gall, Emilie;
Blais, Jaime D.;
Irazabal, Maria V.;
Devuyst, Olivier;
Gansevoort, Ron T.;
Perrone, Ron D.;
Chapman, Arlene B.;
Czerwiec, Frank S.;
Ouyang, John;
Heyer, ChristinaM.;
Senum, Sarah R.;
LeMeur, Yannick;
Torres, Vicente E.;
Harris, Peter C.

Publication type:

Article

Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease: the TEMPO 4:4 Trial.

Published in:

Nephrology Dialysis Transplantation, 2018, v. 33, n. 3, p. 477, doi. 10.1093/ndt/gfx043

By:

Torres, Vicente E.;
Chapman, Arlene B.;
Devuyst, Olivier;
Gansevoort, Ron T.;
Perrone, Ronald D.;
Dandurand, Ann;
Ouyang, John;
Czerwiec, Frank S.;
Blais, Jaime D.

Publication type:

Article

Prevalence of autosomal dominant polycystic kidney disease in the European Union.

Published in:

Nephrology Dialysis Transplantation, 2017, v. 32, n. 8, p. 1356, doi. 10.1093/ndt/gfw240

By:

Willey, Cynthia J.;
Blais, Jaime D.;
Hall, Anthony K.;
Krasa, Holly B.;
Makin, Andrew J.;
Czerwiec, Frank S.

Publication type:

Article

Tolvaptan suppresses monocyte chemotactic protein-1 excretion in autosomal-dominant polycystic kidney disease.

Published in:

Nephrology Dialysis Transplantation, 2017, v. 32, n. 6, p. 969, doi. 10.1093/ndt/gfw060

By:

Grantham, Jared J.;
Chapman, Arlene B.;
Blais, Jaime;
Czerwiec, Frank S.;
Devuyst, Olivier;
Gansevoort, Ron T.;
Higashihara, Eiji;
Krasa, Holly;
Wen Zhou;
Ouyang, John;
Perrone, Ronald D.;
Torres, Vicente E.

Publication type:

Article

Albuminuria and tolvaptan in autosomal-dominant polycystic kidney disease: results of the TEMPO 3:4 Trial.

Published in:

Nephrology Dialysis Transplantation, 2016, v. 31, n. 11, p. 1887, doi. 10.1093/ndt/gfv422

By:

Gansevoort, Ron T.;
Meijer, Esther;
Chapman, Arlene B.;
Czerwiec, Frank S.;
Devuyst, Olivier;
Grantham, Jared J.;
Higashihara, Eiji;
Krasa, Holly B.;
Ouyang, John;
Perrone, Ronald D.;
Torres, Vicente E.

Publication type:

Article

Dexamethasone Suppression Testing in a Contemporary Cohort with Adrenal Incidentalomas in Two U.S. Integrated Healthcare Systems.

Published in:

Biomedicines, 2023, v. 11, n. 12, p. 3167, doi. 10.3390/biomedicines11123167

By:

Crawford, Mackenzie;
McDonald, Bennett;
Chen, Wansu;
Chowdhry, Hina;
Contreras, Richard;
Reyes, Iris Anne C.;
Dhakal, Eleena;
Villanueva, Tish;
Barzilay, Joshua I.;
Vaughn, Candace F.;
Czerwiec, Frank S.;
Katz, David A.;
Adams, Annette L.;
Gander, Jennifer C.

Publication type:

Article

Pharmacokinetics and Pharmacodynamics of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: Phase 2 Trials for Dose Selection in the Pivotal Phase 3 Trial.

Published in:

Journal of Clinical Pharmacology, 2017, v. 57, n. 7, p. 906, doi. 10.1002/jcph.880

By:

Shoaf, Susan E.;
Chapman, Arlene B.;
Torres, Vicente E.;
Ouyang, John;
Czerwiec, Frank S.

Publication type:

Article

Tolvaptan use in cancer patients with hyponatremia due to the syndrome of inappropriate antidiuretic hormone: a post hoc analysis of the SALT-1 and SALT-2 trials.

Published in:

Cancer Medicine, 2017, v. 6, n. 4, p. 723, doi. 10.1002/cam4.805

By:

Gralla, Richard J.;
Ahmad, Fatima;
Blais, Jaime D.;
Chiodo, Joseph;
Zhou, Wen;
Glaser, Linda A.;
Czerwiec, Frank S.

Publication type:

Article

Standardizing total kidney volume measurements for clinical trials of autosomal dominant polycystic kidney disease.

Published in:

Clinical Kidney Journal, 2019, v. 12, n. 1, p. 71, doi. 10.1093/ckj/sfy078

By:

Edwards, Marie E;
Blais, Jaime D;
Czerwiec, Frank S;
Erickson, Bradley J;
Torres, Vicente E;
Kline, Timothy L

Publication type:

Article

Clinical Pattern of Tolvaptan-Associated Liver Injury in Subjects with Autosomal Dominant Polycystic Kidney Disease: Analysis of Clinical Trials Database.

Published in:

2015

By:

Watkins, Paul;
Lewis, James;
Kaplowitz, Neil;
Alpers, David;
Blais, Jaime;
Smotzer, Dan;
Krasa, Holly;
Ouyang, John;
Torres, Vicente;
Czerwiec, Frank;
Zimmer, Christopher;
Watkins, Paul B;
Lewis, James H;
Alpers, David H;
Blais, Jaime D;
Smotzer, Dan M;
Torres, Vicente E;
Czerwiec, Frank S;
Zimmer, Christopher A

Publication type:

journal article

Rationale and Design of a Clinical Trial Investigating Tolvaptan Safety and Efficacy in Autosomal Dominant Polycystic Kidney Disease.

Published in:

2017

By:

Torres, Vicente E.;
Devuyst, Olivier;
Chapman, arlene B.;
Gansevoort, Ron T.;
Perrone, Ronald D.;
Ouyang, John;
Blais, Jaime D.;
Czerwiec, Frank S.;
Sergeyeva, Olga

Publication type:

journal article

Visualization of Fibrous Dysplasia During Somatostatin Receptor Scintigraphy.

Published in:

Journal of Nuclear Medicine, 1998, v. 39, n. 2, p. 238

By:

Chen, Clara C.;
Czerwiec, Frank S.;
Feuillan, Penelope P.

Publication type:

Article

Factitious Cushing Syndrome.

Published in:

Journal of Clinical Endocrinology & Metabolism, 1996, v. 81, n. 10, p. 3573, doi. 10.1210/jc.81.10.3573

By:

CIZZA, GIOVANNI;
NIEMAN, LYNNETTE K.;
DOPPMAN, JOHN L.;
PASSARO, MAUREEN D.;
CZERWIEC, FRANK S.;
CHROUSOS, GEORGE P.;
CUTLER JR., GORDON B.

Publication type:

Article

Short-term renal hemodynamic effects of tolvaptan in subjects with autosomal dominant polycystic kidney disease at various stages of chronic kidney disease.

Published in:

Kidney International, 2013, v. 84, n. 6, p. 1278, doi. 10.1038/ki.2013.285

By:

Boertien, Wendy E;
Meijer, Esther;
de Jong, Paul E;
Bakker, Stephan J L;
Czerwiec, Frank S;
Struck, Joachim;
Oberdhan, Dorothee;
Shoaf, Susan E;
Krasa, Holly B;
Gansevoort, Ron T

Publication type:

Article

Letter to the Editor Further Study of the Therapy for Fibrous Dysplasia Is Necessary.

Published in:

Journal of Bone & Mineral Research, 1997, v. 12, n. 12, p. 2128, doi. 10.1359/jbmr.1997.12.12.2128

By:

Czerwiec, Frank S.;
Collins, Michael;
Feuillan, Penelope;
Shenker, Andrew

Publication type:

Article

Short-term effects of tolvaptan on renal function and volume in patients with autosomal dominant polycystic kidney disease.

Published in:

Kidney International, 2011, v. 80, n. 3, p. 295, doi. 10.1038/ki.2011.119

By:

Irazabal, Maria V.;
Torres, Vicente E.;
Hogan, Marie C.;
Glockner, James;
King, Bernard F;
Ofstie, Troy G.;
Krasa, Holly B.;
Ouyang, John;
Czerwiec, Frank S.

Publication type:

Article